Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2025)

Historic EBITDA Margin for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to 14.51%.

  • GE HealthCare Technologies' EBITDA Margin fell 5500.0% to 14.51% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.4%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 13.4% for FY2025, which is 500.0% up from last year.
  • As of Q4 2025, GE HealthCare Technologies' EBITDA Margin stood at 14.51%, which was down 5500.0% from 12.7% recorded in Q3 2025.
  • GE HealthCare Technologies' 5-year EBITDA Margin high stood at 15.74% for Q4 2022, and its period low was 11.61% during Q1 2024.
  • For the 4-year period, GE HealthCare Technologies' EBITDA Margin averaged around 13.19%, with its median value being 13.11% (2025).
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -25000bps in 2023, then soared by 18200bps in 2024.
  • GE HealthCare Technologies' EBITDA Margin (Quarter) stood at 15.74% in 2022, then decreased by -16bps to 13.23% in 2023, then rose by 14bps to 15.06% in 2024, then dropped by -4bps to 14.51% in 2025.
  • Its EBITDA Margin was 14.51% in Q4 2025, compared to 12.7% in Q3 2025 and 13.06% in Q2 2025.